Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Added Clinical Value of Donor-derived Cell-free DNA for the Monitoring of Cardiac Allograft Rejection: an Observational Prospective Longitudinal Multicenter Study.

NCT06740578 is registered in ClinicalTrials.gov with Paris Translational Research Center for Organ Transplantation as lead sponsor.

NCT NCT06740578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06740578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Added Clinical Value of Donor-derived Cell-free DNA for the Monitoring of Cardiac Allograft Rejection: an Observational Prospective Longitudinal Multicenter Study.
Lead sponsor
Paris Translational Research Center for Organ Transplantation
Phase
Observational
Overall status
Completed
Start date
October 1, 2021
Completion date
October 31, 2023
Enrollment
320 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart transplantation, rejection heart transplant